CSL Appoints Deborah Waterhouse as Chief Executive Officer and Managing Director

CSL Limited's board announced on October 21 that Deborah Waterhouse will become Chief Executive Officer and Managing Director from February 1, 2027. Waterhouse has more than 25 years of experience and has led global specialty pharmaceutical companies in the United States, Britain, continental Europe and Australia. The appointment followed a global search conducted by the board.